22-50456591-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_002972.4(SBF1):​c.3987G>A​(p.Ala1329Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 1,543,372 control chromosomes in the GnomAD database, including 43,767 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 4437 hom., cov: 30)
Exomes 𝑓: 0.22 ( 39330 hom. )

Consequence

SBF1
NM_002972.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.12

Publications

19 publications found
Variant links:
Genes affected
SBF1 (HGNC:10542): (SET binding factor 1) This gene encodes a member of the protein-tyrosine phosphatase family. However, the encoded protein does not appear to be a catalytically active phosphatase because it lacks several amino acids in the catalytic pocket. This protein contains a Guanine nucleotide exchange factor (GEF) domain which is necessary for its role in growth and differentiation. Mutations in this gene have been associated with Charcot-Marie-Tooth disease 4B3. Pseudogenes of this gene have been defined on chromosomes 1 and 8. [provided by RefSeq, Dec 2014]
SBF1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 4B3
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 22-50456591-C-T is Benign according to our data. Variant chr22-50456591-C-T is described in ClinVar as Benign. ClinVar VariationId is 258879.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.688 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SBF1NM_002972.4 linkc.3987G>A p.Ala1329Ala synonymous_variant Exon 30 of 41 ENST00000380817.8 NP_002963.2 O95248-5
SBF1NM_001410794.1 linkc.3990G>A p.Ala1330Ala synonymous_variant Exon 30 of 41 NP_001397723.1
SBF1NM_001365819.1 linkc.3912G>A p.Ala1304Ala synonymous_variant Exon 29 of 40 NP_001352748.1
SBF1NM_001410795.1 linkc.3909G>A p.Ala1303Ala synonymous_variant Exon 29 of 40 NP_001397724.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SBF1ENST00000380817.8 linkc.3987G>A p.Ala1329Ala synonymous_variant Exon 30 of 41 1 NM_002972.4 ENSP00000370196.2 O95248-5

Frequencies

GnomAD3 genomes
AF:
0.210
AC:
31911
AN:
151890
Hom.:
4441
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.104
Gnomad AMI
AF:
0.205
Gnomad AMR
AF:
0.299
Gnomad ASJ
AF:
0.130
Gnomad EAS
AF:
0.708
Gnomad SAS
AF:
0.253
Gnomad FIN
AF:
0.276
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.207
Gnomad OTH
AF:
0.223
GnomAD2 exomes
AF:
0.285
AC:
45396
AN:
159552
AF XY:
0.277
show subpopulations
Gnomad AFR exome
AF:
0.0967
Gnomad AMR exome
AF:
0.406
Gnomad ASJ exome
AF:
0.141
Gnomad EAS exome
AF:
0.712
Gnomad FIN exome
AF:
0.273
Gnomad NFE exome
AF:
0.208
Gnomad OTH exome
AF:
0.236
GnomAD4 exome
AF:
0.219
AC:
304539
AN:
1391362
Hom.:
39330
Cov.:
40
AF XY:
0.219
AC XY:
150160
AN XY:
686146
show subpopulations
African (AFR)
AF:
0.0968
AC:
3057
AN:
31582
American (AMR)
AF:
0.387
AC:
13553
AN:
34998
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
2996
AN:
22292
East Asian (EAS)
AF:
0.701
AC:
26549
AN:
37878
South Asian (SAS)
AF:
0.243
AC:
18176
AN:
74882
European-Finnish (FIN)
AF:
0.279
AC:
13412
AN:
48122
Middle Eastern (MID)
AF:
0.172
AC:
937
AN:
5438
European-Non Finnish (NFE)
AF:
0.197
AC:
212961
AN:
1078882
Other (OTH)
AF:
0.225
AC:
12898
AN:
57288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
12805
25610
38414
51219
64024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7638
15276
22914
30552
38190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.210
AC:
31916
AN:
152010
Hom.:
4437
Cov.:
30
AF XY:
0.217
AC XY:
16158
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.104
AC:
4329
AN:
41478
American (AMR)
AF:
0.299
AC:
4558
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.130
AC:
450
AN:
3470
East Asian (EAS)
AF:
0.707
AC:
3647
AN:
5156
South Asian (SAS)
AF:
0.254
AC:
1222
AN:
4818
European-Finnish (FIN)
AF:
0.276
AC:
2921
AN:
10574
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.207
AC:
14080
AN:
67936
Other (OTH)
AF:
0.222
AC:
468
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1227
2453
3680
4906
6133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.200
Hom.:
646
Bravo
AF:
0.212
Asia WGS
AF:
0.395
AC:
1367
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease type 4B3 Benign:1
May 18, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
7.6
DANN
Benign
0.62
PhyloP100
1.1
PromoterAI
0.032
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5771001; hg19: chr22-50895020; COSMIC: COSV62365326; COSMIC: COSV62365326; API